Posted on January 11, 2022
By Jennifer Snyder | Novartis Pharmaceuticals, Director, Portfolio Strategy Management for Technical Research and Development Cell & Gene Therapy
February 23, 2022
By Jürgen Schrapp | Bayer, Head of R&D Procurement
How I got to start working for BayerWith this article I want to talk about my personal story at Bayer showcasing how much I have experienced openness and inclusion on my way and what I take away from it. I will also spotlight on our recently started Inclusion & Diversity program which includes a focus […]
May 20, 2022
By Jason Rudd | Amgen, Statistical Programming Manager
January 24, 2022
By Alexander M. Haydl | Boehringer Ingelheim Germany, Head of Late-Stage Development Laboratory and Product Owner of Digital Process Development
August 31, 2021
By Teresa Foy | Bristol Myers Squibb, Sr Vice President Immuno-Oncology and Cellular Therapy
January 4, 2022
By Rebekah Martin | AstraZeneca, Senior Vice President of Reward and Inclusion
June 16, 2021
By Rajeev Nair | Merck, Senior Vice President & Head of Asia Pacific - Research Solutions
March 7, 2022
By Vijetha Bhat | Lonza, Houston,Texas, Scientist, Research and Development
November 17, 2021
By Bo Quan Tan | Lonza Singapore, Manager of Project Engineering Department
December 21, 2021
By Kaja Natland | Organon, Regional President, Asia Pacific & Japan
June 24, 2021
By Francis Van Parys | Cytiva, Vice President Commercial Asia Pacific
March 10, 2022
By Elizabeth Jurica | Bristol Myers Squibb, Principal Scientist
January 28, 2022
By Stuart Flanagan | Evotec, Group Leader
August 19, 2021
By Galym Dauletbakov | Takeda, Business Operations Head UCC
